Company / CapEx per Share
Pacira BioSciences, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.33
FY2025
5-year range
$0.23 / $0.67
FY2021-FY2025
Trend
+44.2%
vs FY2024
Sector context
#34 of 192
Health Care
What the data says
Pacira BioSciences, Inc.'s capex per share of $0.33 is higher than 82% of companies in the Health Care sector (FY2025). CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.33.
Based on SEC 10-K filings.
0.33 in FY2025 with a 5-year CAGR of -0.9%. Top quartile in the Health Care sector.
Remained stable around $0.33 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -21.0%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 192This company $0.33 Sector average $2.46
▼
-86.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 44.2% year-over-year.
- Ranks #34 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.33 | +44.2% |
| FY2024 | $0.23 | -30.3% |
| FY2023 | $0.33 | -50.9% |
| FY2022 | $0.67 | +188.8% |
| FY2021 | $0.23 | -32.8% |
| FY2020 | $0.35 | -25.9% |
| FY2019 | $0.47 | -23.1% |
| FY2018 | $0.61 | -43.5% |
| FY2017 | $1.08 | +60.3% |
| FY2016 | $0.67 | -39.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026